Distribution of serum prostate-specific antigen in Chinese healthy men: A population-based study

Chinese Medical Journal

Volumn 124, Issue 8, 2011, Pages 1189-1192

  Yuan, Xiao Dong ^a   Dong, Zhi Gang ^a   Zhang, Hui ^a   Lin, Hai Yan ^a   Song, Xin Hong ^a   Niu, Zhi Hong ^a   Fu, Qiang ^a   Liu, Shuai ^a   Sun, Zhi Jian ^a   Lü, Jia Ju ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Asian; Caucasian; Chinese; Prostate specific antigen; Reference ranges

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ANTIGEN DETECTION; ARTICLE; BLOOD LEVEL; CANCER RISK; CHINESE; CONTROLLED STUDY; CORRELATIONAL STUDY; DIGITAL RECTAL EXAMINATION; HUMAN; MALE; RACE DIFFERENCE;

ADULT; AGE FACTORS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 79955504366     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.08.012     Document Type: Article

References (21)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
2. Harvey P, Basuita A, Endersby D, Curtis B, Iacovidou A, Walker M. A systematic review of the diagnostic accuracy of prostate specific antigen. BMC Urol 2009; 9: 14.
3. Pienta KJ. Critical appraisal of prostate-specific antigen in prostate cancer screening: 20 years later. Urology 2009; 73: 11-20.
4. Bickers B, Aukim-Hastie C. New molecular biomarkers for the prognosis and management of prostate cancer: the post PSA era. Anticancer Res 2009; 29: 3289-3298.
5. Schroder FH. PSA screening: a review of recent studies. Eur J Cancer 2009; 45 Suppl 1: s402-s404.
6. Hoffman RM. Randomized trial results did not resolve controversies surrounding prostate cancer screening. Curr Opin Urol 2010; 20: 189-193.
7. Shteynshlyuger A, Andriole GL. Prostate cancer: to screen or not to screen? Urol Clin North Am 2010; 37: 1-9.
8. Catalona WJ, Smith DS, Ornstein DK. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/ml and benign prostate examination. Enhancement of specificity with free PSA measurements. JAMA 1997; 277: 1452-1455.
9. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, et al. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA 1993; 270: 860-864.
10. El-Galley RE, Petros JA, Sanders WH, Keane TE, Galloway NT, Cooner WH, et al. Normal range prostate-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinoma. Urology 1995;46: 200-204.
11. Morgan TO, Jacobsen SJ, McCarthy WF, Jacobson DJ, McLeod DG, Moul JW. Age-specific reference ranges for prostate-specific antigen in black men. N Engl J Med 1996; 335: 304-310.
12. He D, Wang M, Chen X, Gao Z, He H, Zhau HE, et al. Ethnic differences in distribution of serum prostate-specific antigen: a study in a healthy Chinese male population. Urology 2004; 63: 722-726.
13. Oesterling JE, Kumamoto Y, Tsukamoto T, Girman CJ, Guess HA, Masumori N, et al. Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men. Br J Urol 1995; 75: 347-353.
14. Choi YD, Kang DR, Nam CM, Kim YS, Cho SY, Kim SJ, et al. Age-specific prostate-specific antigen reference ranges in Korean men. Urology 2007; 70: 1113-1116.
15. Kehinde EO, Mojiminiyi OA, Sheikh M, Al-Awadi KA, Daar AS, Al-Hunayan A, et al. Age-specific reference levels of serum prostate-specific antigen and prostate volume in healthy Arab men. BJU Int 2005; 96: 308-312.
16. Lin WY, Gu CJ, Kao CH, Changlai SP, Wang SJ. Serum prostate-specific antigen in healthy Chinese men: establishment of age-specific reference ranges. Neoplasma 1996; 43: 103-105.
17. Kuwahara M, Tochigi T, Kawamura S, Ogata Y, Xu N, Wang H, et al. Mass screening for prostate cancer: a comparative study in Natori, Japan and Changchun, China. Urology 2003; 61: 137-141.
18. Weinrich MC, Jacobsen SJ, Weinrich SP, Moul JW, Oesterling JE, Jacobson D, et al. Reference ranges for serum prostate-specific antigen in black and white men without cancer. Urology 1998; 52: 967-973.
19. Ishibashi M. Standardization of prostate-specific antigen (PSA) assays: can interchangeability of PSA measurements be improved? Clin Chem 2006; 52: 1-2.
20. Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009; 360: 1310-1319.
21. Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al. Screening and prostate-cancer motality in a randomized European study. N Engl J Med 2009; 360: 1320-1328.